Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for CRMD

Stock Name	CorMedix Inc
Ticker	CRMD(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US21900C3088
LEI	5299006YIA3L0MBW8358

Show aggregate CRMD holdings

News associated with CRMD

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win: Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Analysts Set CorMedix Inc (NASDAQ:CRMD) Price Target at $17.33: CorMedix Inc (NASDAQ:CRMD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the […] - 2025-09-01 03:01:01
CorMedix (NASDAQ:CRMD) Lowered to “Buy” Rating by Wall Street Zen: CorMedix (NASDAQ:CRMD – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other equities analysts have also recently weighed in on the stock. D Boral Capital cut shares of CorMedix […] - 2025-08-11 05:06:55
CorMedix (NASDAQ:CRMD) Given New $17.00 Price Target at HC Wainwright: CorMedix (NASDAQ:CRMD – Free Report) had its target price decreased by HC Wainwright from $20.00 to $17.00 in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for CorMedix’s Q3 2025 earnings at $0.33 EPS. A number of other equities analysts have […] - 2025-08-11 04:08:44
Arizona State Retirement System Makes New $107,000 Investment in CorMedix Inc (NASDAQ:CRMD): Arizona State Retirement System acquired a new position in CorMedix Inc (NASDAQ:CRMD – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 17,396 shares of the company’s stock, valued at approximately $107,000. A number of other institutional investors […] - 2025-07-24 04:38:52
Teacher Retirement System of Texas Invests $98,000 in CorMedix Inc (NASDAQ:CRMD): Teacher Retirement System of Texas bought a new stake in CorMedix Inc (NASDAQ:CRMD – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,981 shares of the company’s stock, valued at approximately $98,000. A number of other institutional investors have also […] - 2025-07-22 04:12:50
CorMedix Inc (NASDAQ:CRMD) Receives $17.14 Average Target Price from Analysts: Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation […] - 2025-07-15 03:51:08
Essex Financial Services Inc. Buys New Shares in CorMedix Inc (NASDAQ:CRMD): Essex Financial Services Inc. purchased a new position in CorMedix Inc (NASDAQ:CRMD – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,263 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds also recently made changes to their positions […] - 2025-07-03 06:15:00
CorMedix (NASDAQ:CRMD) Cut to “Hold” at D Boral Capital: D Boral Capital downgraded shares of CorMedix (NASDAQ:CRMD – Free Report) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports. Several other analysts have also recently commented on CRMD. D. Boral Capital cut CorMedix from a “buy” rating to a “hold” rating in a research report on […] - 2025-07-03 05:23:10
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 14:12:26
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 12:18:35
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 10:17:03
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 08:36:28
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 03:48:41
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. September E-mini S&P futures (ESU25 ) are up +0.42%, and September E-mini Nasdaq futures... - 2025-06-30 02:40:04
Stocks Rally on Hopes of Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.89%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.52%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-06-27 14:33:35
S&P 500 and Nasdaq 100 Post Record Highs on Hopes of Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.33%. September E-mini S&P futures (ESU25 ) are up +0.27%, and September E-mini Nasdaq futures... - 2025-06-27 13:55:48
S&P 500 and Nasdaq 100 Post Record Highs on Hopes of Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.33%. September E-mini S&P futures (ESU25 ) are up +0.27%, and September E-mini Nasdaq futures... - 2025-06-27 12:45:08
Needham & Company LLC Raises CorMedix (NASDAQ:CRMD) Price Target to $20.00: CorMedix (NASDAQ:CRMD – Get Free Report) had its price objective increased by research analysts at Needham & Company LLC from $15.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of […] - 2025-06-26 02:48:48
D. Boral Capital Reaffirms Buy Rating for CorMedix (NASDAQ:CRMD): CorMedix (NASDAQ:CRMD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. D. Boral Capital’s price target would suggest a potential downside of 4.58% from the company’s current price. Several other […] - 2025-06-25 02:36:50
CorMedix Inc (NASDAQ:CRMD) Receives $15.00 Average Target Price from Analysts: Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been assigned an average rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-06-18 02:26:51
Northern Trust Corp Has $4.14 Million Stake in CorMedix Inc. (NASDAQ:CRMD): Northern Trust Corp raised its position in CorMedix Inc. (NASDAQ:CRMD – Free Report) by 14.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 511,565 shares of the company’s stock after purchasing an additional 64,243 shares during the quarter. Northern Trust Corp’s holdings in […] - 2025-05-23 05:26:53
CorMedix Inc. (NASDAQ:CRMD) Given Consensus Recommendation of “Buy” by Brokerages: Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have earned an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among […] - 2025-05-21 04:48:43
D. E. Shaw & Co. Inc. Has $3.62 Million Holdings in CorMedix Inc. (NASDAQ:CRMD): D. E. Shaw & Co. Inc. raised its stake in CorMedix Inc. (NASDAQ:CRMD – Free Report) by 39.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 446,414 shares of the company’s stock after acquiring an additional 125,425 shares during the quarter. D. […] - 2025-05-19 05:10:50
CorMedix (NASDAQ:CRMD) Sees Unusually-High Trading Volume on Strong Earnings: CorMedix Inc. (NASDAQ:CRMD – Get Free Report) saw an uptick in trading volume on Wednesday following a stronger than expected earnings report. 3,436,993 shares were traded during mid-day trading, an increase of 220% from the previous session’s volume of 1,074,103 shares.The stock last traded at $11.38 and had previously closed at $11.16. The company reported […] - 2025-05-09 02:58:43
CorMedix (NASDAQ:CRMD) Shares Gap Up on Earnings Beat: CorMedix Inc. (NASDAQ:CRMD – Get Free Report)’s share price gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $9.03, but opened at $9.59. CorMedix shares last traded at $10.36, with a volume of 716,204 shares traded. The company reported $0.30 EPS for the quarter, […] - 2025-05-08 02:25:25
CorMedix Inc. (NASDAQ:CRMD) Receives $14.50 Consensus PT from Brokerages: Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have received an average rating of “Buy” from the seven analysts that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year target price among […] - 2025-05-01 04:54:49
CorMedix Inc. (NASDAQ:CRMD) Shares Sold by Wellington Management Group LLP: Wellington Management Group LLP lessened its position in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) by 1.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 178,786 shares of the company’s stock after selling 2,162 shares during the period. Wellington Management Group LLP’s […] - 2025-04-14 04:50:52
D. Boral Capital Reaffirms “Buy” Rating for CorMedix (NASDAQ:CRMD): D. Boral Capital reaffirmed their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $15.00 target price on the stock. Several other equities analysts also recently weighed in on CRMD. Royal Bank of Canada restated an “outperform” rating […] - 2025-04-11 04:32:51
CorMedix Logs Q1 Prel. Revenue Of $39 Mln: (RTTNews) - CorMedix Inc. (CRMD), a biopharmaceutical company, Tuesday reported preliminary revenue of $39 million for the first quarter. In the previous-year quarter, the company did not receive any revenue. - 2025-04-08 09:01:32

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) CRMD holdings

Date	Number of CRMD Shares Held	Base Market Value of CRMD Shares	Local Market Value of CRMD Shares	Change in CRMD Shares Held	Change in CRMD Base Value	Current Price per CRMD Share Held	Previous Price per CRMD Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRMD by Blackrock for IE00BYXG2H39

Show aggregate share trades of CRMD

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-06 BUY 354 11.560 11.710 11.695 USD 4,140 11.22
2025-10-03 BUY 826 11.340 11.420 11.412 USD 9,426 11.22
2025-10-02 BUY 118 11.050 11.190 11.176 USD 1,319 11.22
2025-09-30 BUY 236 11.630 12.290 12.224 USD 2,885 11.22
2025-09-26 BUY 236 11.300 11.380 11.372 USD 2,684 11.22
2025-09-25 BUY 236 11.120 11.340 11.318 USD 2,671 11.22
2025-09-18 BUY 119 11.690 11.760 11.753 USD 1,399 11.22
2025-09-17 BUY 357 11.120 11.750 11.687 USD 4,172 11.22
2025-09-11 SELL -118 13.090 13.340 13.315 USD -1,571 11.19 Loss of -251 on sale
2025-09-10 BUY 236 12.790 13.480 13.411 USD 3,165 11.18
2025-09-05 SELL -118 12.400 12.910 12.859 USD -1,517 11.15 Loss of -202 on sale
2025-08-29 SELL -354 14.830 14.960 14.947 USD -5,291 11.07 Loss of -1,371 on sale
2025-08-27 BUY 234 14.140 14.400 14.374 USD 3,364 11.03
2025-08-26 SELL -117 13.990 14.050 14.044 USD -1,643 11.02 Loss of -354 on sale
2025-08-25 BUY 118 13.730 14.140 14.099 USD 1,664 11.00
2025-08-20 SELL -468 13.520 13.700 13.682 USD -6,403 10.97 Loss of -1,271 on sale
2025-08-18 BUY 234 13.100 13.560 13.514 USD 3,162 10.94
2025-08-08 SELL -234 10.330 11.230 11.140 USD -2,607 10.93 Loss of -50 on sale
2025-08-05 BUY 117 12.060 12.480 12.438 USD 1,455 10.91
2025-08-01 SELL -350 11.640 11.680 11.676 USD -4,087 10.90 Loss of -272 on sale
2025-07-30 BUY 468 11.540 12.020 11.972 USD 5,603 10.89
2025-07-17 SELL -234 11.070 11.310 11.286 USD -2,641 10.86 Loss of -100 on sale
2025-07-11 SELL -936 11.220 11.730 11.679 USD -10,932 10.84 Loss of -781 on sale
2025-07-07 BUY 351 11.420 11.740 11.708 USD 4,110 10.83
2025-07-02 BUY 6,435 11.590 11.860 11.833 USD 76,145 10.81
2025-06-25 BUY 234 14.970 15.650 15.582 USD 3,646 10.71
2025-06-20 BUY 4,002 13.610 13.890 13.862 USD 55,476 10.59
2025-06-11 BUY 208 14.590 15.380 15.301 USD 3,183 10.36
2025-06-10 BUY 208 14.890 15.320 15.277 USD 3,178 10.32
2025-06-04 SELL -104 12.380 12.740 12.704 USD -1,321 10.20 Loss of -260 on sale
2025-04-23 BUY 105 8.450 8.760 8.729 USD 917 9.79
2025-04-10 SELL -840 6.840 7.070 7.047 USD -5,919 10.09 Profit of 2,559 on sale
2025-04-08 SELL -105 6.790 7.710 7.618 USD -800 10.19 Profit of 270 on sale
2025-04-07 SELL -105 6.070 6.290 6.268 USD -658 10.26 Profit of 419 on sale
2025-04-04 SELL -535 5.860 6.030 6.013 USD -3,217 10.33 Profit of 2,310 on sale
2025-04-01 BUY 428 6.070 6.180 6.169 USD 2,640 10.47
2025-03-31 SELL -321 6.160 6.640 6.592 USD -2,116 10.54 Profit of 1,268 on sale
2025-03-21 BUY 2,305 10.910 11.170 11.144 USD 25,687 10.80
2025-03-14 SELL -1,584 10.470 10.640 10.623 USD -16,827 10.81 Profit of 304 on sale
2025-03-07 SELL -198 10.710 10.850 10.836 USD -2,146 10.83 Loss of -1 on sale
2025-03-04 SELL -99 9.850 9.940 9.931 USD -983 10.91 Profit of 97 on sale
2025-02-25 BUY 198 10.290 10.330 10.326 USD 2,045 11.01
2025-02-19 SELL -98 11.180 11.280 11.270 USD -1,104 11.07 Loss of -20 on sale
2025-02-13 BUY 291 10.440 10.530 10.521 USD 3,062 11.15
2025-02-12 BUY 97 10.000 10.170 10.153 USD 985 11.19
2025-02-11 BUY 388 10.050 10.260 10.239 USD 3,973 11.24
2025-01-17 BUY 388 12.170 13.090 12.998 USD 5,043 11.01
2025-01-16 BUY 388 12.790 12.890 12.880 USD 4,997 10.75
2025-01-10 SELL -194 11.190 11.240 11.235 USD -2,180 9.95 Loss of -250 on sale
2025-01-08 SELL -392 10.810 11.000 10.981 USD -4,305 8.22 Loss of -1,082 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-06	BUY	354	11.560	11.710	11.695	USD 4,140	11.22
2025-10-03	BUY	826	11.340	11.420	11.412	USD 9,426	11.22
2025-10-02	BUY	118	11.050	11.190	11.176	USD 1,319	11.22
2025-09-30	BUY	236	11.630	12.290	12.224	USD 2,885	11.22
2025-09-26	BUY	236	11.300	11.380	11.372	USD 2,684	11.22
2025-09-25	BUY	236	11.120	11.340	11.318	USD 2,671	11.22
2025-09-18	BUY	119	11.690	11.760	11.753	USD 1,399	11.22
2025-09-17	BUY	357	11.120	11.750	11.687	USD 4,172	11.22
2025-09-11	SELL	-118	13.090	13.340	13.315	USD -1,571	11.19 Loss of -251 on sale
2025-09-10	BUY	236	12.790	13.480	13.411	USD 3,165	11.18
2025-09-05	SELL	-118	12.400	12.910	12.859	USD -1,517	11.15 Loss of -202 on sale
2025-08-29	SELL	-354	14.830	14.960	14.947	USD -5,291	11.07 Loss of -1,371 on sale
2025-08-27	BUY	234	14.140	14.400	14.374	USD 3,364	11.03
2025-08-26	SELL	-117	13.990	14.050	14.044	USD -1,643	11.02 Loss of -354 on sale
2025-08-25	BUY	118	13.730	14.140	14.099	USD 1,664	11.00
2025-08-20	SELL	-468	13.520	13.700	13.682	USD -6,403	10.97 Loss of -1,271 on sale
2025-08-18	BUY	234	13.100	13.560	13.514	USD 3,162	10.94
2025-08-08	SELL	-234	10.330	11.230	11.140	USD -2,607	10.93 Loss of -50 on sale
2025-08-05	BUY	117	12.060	12.480	12.438	USD 1,455	10.91
2025-08-01	SELL	-350	11.640	11.680	11.676	USD -4,087	10.90 Loss of -272 on sale
2025-07-30	BUY	468	11.540	12.020	11.972	USD 5,603	10.89
2025-07-17	SELL	-234	11.070	11.310	11.286	USD -2,641	10.86 Loss of -100 on sale
2025-07-11	SELL	-936	11.220	11.730	11.679	USD -10,932	10.84 Loss of -781 on sale
2025-07-07	BUY	351	11.420	11.740	11.708	USD 4,110	10.83
2025-07-02	BUY	6,435	11.590	11.860	11.833	USD 76,145	10.81
2025-06-25	BUY	234	14.970	15.650	15.582	USD 3,646	10.71
2025-06-20	BUY	4,002	13.610	13.890	13.862	USD 55,476	10.59
2025-06-11	BUY	208	14.590	15.380	15.301	USD 3,183	10.36
2025-06-10	BUY	208	14.890	15.320	15.277	USD 3,178	10.32
2025-06-04	SELL	-104	12.380	12.740	12.704	USD -1,321	10.20 Loss of -260 on sale
2025-04-23	BUY	105	8.450	8.760	8.729	USD 917	9.79
2025-04-10	SELL	-840	6.840	7.070	7.047	USD -5,919	10.09 Profit of 2,559 on sale
2025-04-08	SELL	-105	6.790	7.710	7.618	USD -800	10.19 Profit of 270 on sale
2025-04-07	SELL	-105	6.070	6.290	6.268	USD -658	10.26 Profit of 419 on sale
2025-04-04	SELL	-535	5.860	6.030	6.013	USD -3,217	10.33 Profit of 2,310 on sale
2025-04-01	BUY	428	6.070	6.180	6.169	USD 2,640	10.47
2025-03-31	SELL	-321	6.160	6.640	6.592	USD -2,116	10.54 Profit of 1,268 on sale
2025-03-21	BUY	2,305	10.910	11.170	11.144	USD 25,687	10.80
2025-03-14	SELL	-1,584	10.470	10.640	10.623	USD -16,827	10.81 Profit of 304 on sale
2025-03-07	SELL	-198	10.710	10.850	10.836	USD -2,146	10.83 Loss of -1 on sale
2025-03-04	SELL	-99	9.850	9.940	9.931	USD -983	10.91 Profit of 97 on sale
2025-02-25	BUY	198	10.290	10.330	10.326	USD 2,045	11.01
2025-02-19	SELL	-98	11.180	11.280	11.270	USD -1,104	11.07 Loss of -20 on sale
2025-02-13	BUY	291	10.440	10.530	10.521	USD 3,062	11.15
2025-02-12	BUY	97	10.000	10.170	10.153	USD 985	11.19
2025-02-11	BUY	388	10.050	10.260	10.239	USD 3,973	11.24
2025-01-17	BUY	388	12.170	13.090	12.998	USD 5,043	11.01
2025-01-16	BUY	388	12.790	12.890	12.880	USD 4,997	10.75
2025-01-10	SELL	-194	11.190	11.240	11.235	USD -2,180	9.95 Loss of -250 on sale
2025-01-08	SELL	-392	10.810	11.000	10.981	USD -4,305	8.22 Loss of -1,082 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRMD

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	690,899	0	1,630,544	42.4%
2025-09-18	708,943	0	1,730,528	41.0%
2025-09-17	1,000,929	2,443	2,165,275	46.2%
2025-09-16	857,795	4,576	1,988,398	43.1%
2025-09-15	524,180	2,369	1,121,913	46.7%
2025-09-12	440,016	6,374	844,376	52.1%
2025-09-11	491,300	250	1,228,100	40.0%
2025-09-10	552,963	2,156	1,474,841	37.5%
2025-09-09	1,044,538	490	2,790,722	37.4%
2025-09-08	1,001,071	8,377	2,020,716	49.5%
2025-09-05	1,122,348	26,486	2,126,527	52.8%
2025-09-04	1,166,164	3,905	2,470,110	47.2%
2025-09-03	877,409	3,462	1,943,530	45.1%
2025-09-02	3,653,677	1,854	6,032,636	60.6%
2025-08-29	615,707	112	1,297,226	47.5%
2025-08-28	750,785	0	1,706,229	44.0%
2025-08-27	833,071	400	1,737,991	47.9%
2025-08-26	553,974	600	1,097,042	50.5%
2025-08-25	558,648	0	939,330	59.5%
2025-08-22	720,713	0	1,466,789	49.1%
2025-08-21	717,984	0	1,613,174	44.5%
2025-08-20	727,498	778	1,603,261	45.4%
2025-08-19	685,782	1,254	1,271,569	53.9%
2025-08-18	554,645	1,032	1,156,955	47.9%
2025-08-15	549,845	0	980,776	56.1%
2025-08-14	481,267	0	1,027,415	46.8%
2025-08-13	897,618	1,449	1,626,284	55.2%
2025-08-12	1,018,809	3,690	2,214,082	46.0%
2025-08-11	1,349,564	228	1,823,957	74.0%
2025-08-08	1,917,290	42,476	3,013,016	63.6%
2025-08-07	3,402,382	180,334	5,583,844	60.9%
2025-08-06	219,984	0	397,566	55.3%
2025-08-05	264,065	3,254	623,853	42.3%
2025-08-04	388,252	0	909,589	42.7%
2025-08-01	414,283	0	726,723	57.0%
2025-07-31	183,762	0	467,612	39.3%
2025-07-30	388,927	0	709,227	54.8%
2025-07-29	334,896	465	616,875	54.3%
2025-07-28	536,633	0	1,001,304	53.6%
2025-07-25	461,699	0	868,925	53.1%
2025-07-24	447,264	211	956,457	46.8%
2025-07-23	1,197,034	417	1,967,730	60.8%
2025-07-22	330,008	0	644,407	51.2%
2025-07-21	216,522	1,138	360,030	60.1%
2025-07-18	236,013	292	455,534	51.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE